ChemicalBook > CAS DataBase List > Mobocertinib

Mobocertinib

Binding Mode

Product Name: Mobocertinib
CAS No.: 1847461-43-1
Chemical Name: Mobocertinib
Synonyms: Mobocertinib;Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate;Mobocertinib (TAK788);5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester;TAK-788;Mobutinib;TAK788 TAK-788;ak-788 Mobotinib;Mobutinib TAK788;AP32788, MOBOCERTINIB
CBNumber: CB74676602
Molecular Formula: C32H39N7O4
Formula Weight: 585.71
MOL File: 1847461-43-1.mol

Less

Mobocertinib Property

storage temp.: Store at -20°C
solubility: DMF: 10 mg/ml,DMF:PBS (pH 7.2) (1:8): 0.11 mg/ml
form: A crystalline solid
color: Off-white to light yellow
InChIKey: AZSRSNUQCUDCGG-UHFFFAOYSA-N
SMILES: C(C1=CN=C(NC2C=C(NC(=O)C=C)C(N(C)CCN(C)C)=CC=2OC)N=C1C1=CN(C)C2=CC=CC=C12)(=O)OC(C)C

Less

Hazard and Precautionary Statements (GHS)

Less

N-Bromosuccinimide Price

ChemScene

Product number: CS-0114256
Product name: Mobocertinib
Purity: 98.92%
Packaging: 10mg
Price: $60
Updated: 2021/12/16

ChemScene

Product number: CS-0114256
Product name: Mobocertinib
Purity: 98.92%
Packaging: 100mg
Price: $250
Updated: 2021/12/16

ChemScene

Product number: CS-0114256
Product name: Mobocertinib
Purity: 98.92%
Packaging: 500mg
Price: $950
Updated: 2021/12/16

DC Chemicals

Product number: 013004
Product name: Mobocertinib(TAK-788)
Packaging: 003
Price: $1800
Updated: 2021/12/16

DC Chemicals

Product number: 013004
Product name: Mobocertinib(TAK-788)
Packaging: 001
Price: $450
Updated: 2021/12/16

Less

Mobocertinib Chemical Properties,Usage,Production

Binding Mode

In the co-crystal structure of moboceritinib in complex with EGFRT790M+V948R, the aminopyrimidine scaffold occupies the ATP-binding site, forming two critical hydrogen bonds with Met793 of the hinge, and the isopropyl ester occupies a selectivity pocket in the vicinity of αC helix. The ester carbonyl group interacts with Gln791 backbone carbonyl via a bound water molecule. Most importantly, the inhibitor forms the expected covalent bond with Cys797 at the edge of the active site cleft and the acrylamide Michael--acceptor group, making binding irreversible. The co-crystal structure of wt EGFR kinase in complex with moboceritinib shows that the ester group is slightly tilted to enable a hydrogen bond between the Thr790 gatekeeper side chain hydroxyl group and the ester carbonyl oxygen. However, a comparison of the wt and mutant proteins with moboceritinib reveals that the binding pockets are similar despite differences in overall kinase conformation.

Description

Mobocertinib is derived from osimertinib, a second-generation TKI which exhibits only limited activity against several resistant EGFRex20ins mutants. Both inhibitors are structurally identical except that the pyrimidine ring of moboceritinib incorporates a snugly fitting isopropyl ester group that targets a previously unoccupied pocket, resulting in expanded coverage of EGFRex20ins mutations as well as improved selectivity over wildtype EGFR vs. osimertinib.

Uses

Mobocertinib (TAK-788) is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib effectively inhibits oncogenic variants containing mutations that activate the EGFRex20ins, with selectivity superior to that of wild-type EGFR. Mobocertinib is FDA-approved for the treatment of patients with non-small cell lung cancer (NSCLC) who have a HER2 mutation or an EGFR mutation, including an exon 20 insertion mutation. Mobocertinib is approved by the FDA for the treatment of patients with non-small cell lung cancer (NSCLC) who have HER2 mutations or EGFR mutations, including exon 20 insertion mutations.

brand name

Exkivity^TM

General Description

Class: receptor tyrosine kinase
Treatment: NSCLC with EGFR alterations
Oral bioavailability = 37%
Elimination half-life = 18 h

Biological Activity

In NSCLC cell lines, mobocertinib was highly active against common EGFR-activating mutations (exon 19 deletions and L858R) (IC50 = 1.3–4.0 nM) or with a gatekeeper T790M mutant (IC50 = 9.8 nM), as well as selective for wt EGFR (IC50 = 35 nM). In Ba/F3 cells, mobocertinib displayed activity against 14 EGFR mutations with IC50 values ranging from 2.7 to 22.5 nM, vs. 34.5 nM for wt EGFR. More specifically, mobocertinib inhibited all five variants of EGFRex20ins mutations with IC50 ranging from 4.3 nM to 22.5 nM.

Mechanism of action

Mobocertinib is a tyrosine kinase inhibitor (TKI) designed specifically to target EGFR exon 20 insertion mutations, which occur in approximately 2% of all NSCLCs and 4-12% of NSCLCs with EGFR mutations.

Synthesis

The synthesis of mobocertinib is shown below. The dichloropyrimidine (27.1) was first synthesized by Friedel-Crafts arylation with indole (27.2), followed by a SNAr reaction to displace the second pyrimidine chloride to an aniline (27.4). Subsequently, a second SNAr reaction was performed in which the aryl fluoride (27.5) reacted with trimethylethylenediamine (27.6) and the nitro group was reduced to afford the aniline (27.8). The introduction of the acrylamide moiety was performed in two steps: first, by T3P amidation with 27.9, to introduce the β-sulfonamide (27.10), followed by elimination using potassium trimethylsilanol to afford 27.11. Finally, by treating 27.11 with succinic acid (27.12) in ethanol, the orally administered mobocertinib (27) was formed as a succinate.

target

EGFR, HER2-4

Metabolism

Moboceritinib undergoes CYP450-mediated metabolism to give two primary N-demethylated metabolites, AP32914 and AP32960, whose IC50 values are within 2-fold of mobocertinib for both wt and mutant EGFR. It is likely that these metabolites also contribute to the pharmacologic activity of mobocertinib. Interestingly, the typically labile isopropyl ester appears resistant to esterase-induced hydrolysis.

Mobocertinib Preparation Products And Raw materials

Raw materials

Preparation Products

Less

Mobocertinib Suppliers

China 134 India 3 United States 5 Global 142

Jinan shenlikang chemical technology co. LTD

Tel: 0531-86092839 13153040268
Fax: QQ：2425815073
Email: 2425815073@qq.com
Country: China
ProdList: 265
Advantage: 58

Jinan Chuanbei Biotechnology Co., Ltd

Tel: 18654547380; 15269175648
Fax: 0531-67802093
Email: qingyan7590@163.com
Country: China
ProdList: 22
Advantage: 58

JINAN RUIFENG PHARMACEUTICAL TECHNOLOGY CO.,LTD

Tel: 18668921571 18668921571;
Email: liujnlz@126.com
Country: China
ProdList: 22
Advantage: 58

Nantong Hanfang Biotechnology Co. , Ltd.

Tel: hanfangpharma@126.com; 18616537568
Email: hanfangpharma@126.com
Country: China
ProdList: 29965
Advantage: 58

Chembest Research Laboratories Limited

Tel: +86-21-20908456
Fax: 021-58180499
Email: sales@BioChemBest.com
Country: China
ProdList: 6003
Advantage: 61

Nanjing Chemlin Chemical Co., Ltd

Tel: 025-83697070
Fax: +86-25-83453306
Email: info@chemlin.com.cn
Country: China
ProdList: 15883
Advantage: 64

Shanghai Run-Biotech Co., Ltd.

Tel: 021-57171705 13817537615
Fax: QQ3095748324
Email: sales@run-biotech.com
Country: China
ProdList: 2337
Advantage: 58

TargetMol Chemicals Inc.

Tel: 021-021-33632979 15002134094
Fax: 021-33632979
Email: marketing@targetmol.com
Country: China
ProdList: 7783
Advantage: 58

ShangHai Caerulum Pharma Discovery Co., Ltd.

Tel: 18149758185
Email: sales-cpd@caerulumpharma.com
Country: China
ProdList: 3506
Advantage: 58

Suzhou NMT Biotech Co., Ltd.

Tel: 0512-62388427 18012730781
Fax: QQ2403880319
Email: longchengnmt@gmail.com
Country: China
ProdList: 42
Advantage: 58

Hangzhou J&H Chemical Co., Ltd.

Tel: 0571-87396432
Fax: 0571-87396431
Email: sales@jhechem.com
Country: China
ProdList: 14912
Advantage: 59

Shanghai YuanQi Biotechnology Co., Ltd.

Tel: +86-2332782371 +86-18120098618
Email: sales@adobechem.com
Country: China
ProdList: 1250
Advantage: 50

Shanghai Lollane Biological Technology Co.,Ltd.

Tel: 021-52996696，15000506266 15000506266
Fax: +86-21-52996696
Country: China
ProdList: 4757
Advantage: 55

Taizhou Ruixin Chemical Co., Ltd.

Tel: 0576-89085261 15867635987
Fax: 0576-89085262
Email: jasonhu09@163.com
Country: China
ProdList: 442
Advantage: 50

shandong XuanHong Pharmaceutical Technology Co.,Ltd

Tel: +86-0531-88801869 15090917080
Fax: 0531-88801867
Email: sciencechem@163.com
Country: China
ProdList: 283
Advantage: 55

Shanghai YuanYe Biotechnology Co., Ltd.

Tel: 021-61312847; 18021002903
Fax: QQ:3008007432
Email: 3008007409@qq.com
Country: China
ProdList: 71826
Advantage: 60

Cangzhou Enke Pharma-tech Co., Ltd.

Tel: 0317-5296180 15533709196
Fax: 0317-5106596
Email: sale@enkepharma.com
Country: China
ProdList: 2267
Advantage: 55

ShangHai Biochempartner Co.,Ltd

Tel: 177-54423994 17754423994
Fax: QQ:2853530913
Email: 2853530910@QQ.com
Country: China
ProdList: 8000
Advantage: 62

Shanghai Chaolan Chemical Technology Center

Tel: 021-QQ：65489617 15618227136
Fax: 21-5161 9052
Email: Sales@ATKchemical.com
Country: China
ProdList: 9125
Advantage: 58

Beijing Jin Ming Biotechnology Co., Ltd.

Tel: 010-60605840 18892239720
Fax: 010-60605840
Email: psaitong@jm-bio.com
Country: China
ProdList: 12306
Advantage: 58

Chuzhou KeMail Chemical Technology Co., Ltd

Tel: 0550-5196001 15000891977
Fax: 0550-5196001
Email: wj520wjxby@126.com
Country: China
ProdList: 1944
Advantage: 55

Wellman Pharmaceutical Group Limited

Tel: 027-027-83778875 15807197853
Fax: 027-83991220
Email: 15807197853@163.com
Country: China
ProdList: 3931
Advantage: 58

Chemleader Biomedical Co., Limited.

Tel: 021-58180488
Fax: 021-58180499
Email: sales@MedChemLeader.com
Country: China
ProdList: 1006
Advantage: 58

Jiaxing Deyi Chemical Co., Ltd.

Tel: 86-0573-85866609 13325730825
Fax: 0573-85866609
Email: 945717149@qq.com
Country: China
ProdList: 8593
Advantage: 58

Shandong Chenxi Pharmaceutical Co., Ltd.

Tel: +86-0531-88803416 13153166250
Fax: 0531-88803416
Email: sales@chemedpharma.com
Country: China
ProdList: 199
Advantage: 58

Twochem Co.Ltd.

Tel: 021-58111628 15800915896
Fax: QQ 3285589261
Email: sales@twochem.com
Country: China
ProdList: 1788
Advantage: 58

Changzhou Yongfeng Biomedicine Co. Ltd.

Tel: 15006117673
Fax: 2973592490@.com
Email: 2973592490@qq.com
Country: China
ProdList: 299
Advantage: 58

Jinan Guoding Pharmaceutical Technology Co., Ltd.

Tel: 053167801621 15665775653
Fax: 053167801621
Email: sales@guodingpharma.com
Country: China
ProdList: 491
Advantage: 58

Zhejiang J&C Biological Technology Co.,Limited

Tel: +1-2135480471
Email: sales@sarms4muscle.com
Country: China
ProdList: 10473
Advantage: 58

ANHUI WITOP BIOTECH CO., LTD

Tel: +8615255079626
Email: eric@witopchemical.com
Country: China
ProdList: 23541
Advantage: 58

Shanghai UCHEM Inc.

Tel: +862156762820 +86-13564624040
Email: sales@myuchem.com
Country: China
ProdList: 8460
Advantage: 58

Wuhan Demeikai Biotechnology Co., Ltd

Tel: +8618942921723
Email: info@dmksw.xin
Country: China
ProdList: 717
Advantage: 58

Career Henan Chemica Co

Tel: +86-0371-86658258 +8613203830695
Fax: 0371-86658258
Email: laboratory@coreychem.com
Country: China
ProdList: 30229
Advantage: 58

HANGZHOU CLAP TECHNOLOGY CO.,LTD

Tel: 86-571-88216897,88216896 13588875226
Fax: 86-571-88216895
Email: sales@hzclap.com
Country: CHINA
ProdList: 6312
Advantage: 58

Changzhou Chenhong Biotechnology Co., Ltd.

Tel: +86-0519-85788828 +86-13775037613
Email: sales@chemrenpharm.com
Country: China
ProdList: 3934
Advantage: 58

Wuhan Shuangjin Fine Chemical Co., Ltd.

Tel: 027-51903003 15926256169
Fax: 027-51903003
Email: 773164315@qq.com
Country: China
ProdList: 60
Advantage: 58

Wuxi Kehua Biological Technology Co., Ltd.

Tel: 0510-86838766 13636419861
Email: 2258830676@qq.com
Country: China
ProdList: 5044
Advantage: 58

Beijing xinyanhui pharmaceutical research and development co., LTD

Tel: 13969155946
Email: 1461866103@qq.com
Country: China
ProdList: 16111
Advantage: 58

Shanghai Yanze Chemical Co., Ltd.

Tel: 021-021-13773155751 19975051755
Email: 260924549@qq.com
Country: China
ProdList: 10524
Advantage: 58

Hengyang Jiaxuan Biotechnology Co. LTD

Tel: 18684598761
Fax: QQ：675042965
Email: 675042965@qq.com
Country: China
ProdList: 308
Advantage: 58

Wuxi Donghe Pharmaceutical Technology Co., Ltd.

Tel: 63313187 15358055255
Fax: QQ：63313187
Email: 63313187@qq.com
Country: China
ProdList: 1984
Advantage: 58

Liuyang huarui material technology co., ltd.

Tel: 13467605171
Fax: 0731-83285201
Email: 2580432242@qq.com
Country: China
ProdList: 184
Advantage: 58

Wuhan Dingtong Pharmaceutical Co., Ltd

Tel: 027-027-59207795 18327179646
Fax: 027-59207795
Email: 18327179646@163.com
Country: China
ProdList: 1986
Advantage: 58

Hubei Junxian Biotechnology Co., Ltd

Tel: 18908622922
Email: 3464928989@qq.com
Country: China
ProdList: 46
Advantage: 58

Nanjing shengyilai Chemical Co., Ltd

Tel: 19951936396
Email: 3158688292@qq.com
Country: China
ProdList: 4856
Advantage: 58

Shanghai Luofa Biochemical Technology Co., Ltd.

Tel: 021-51111890 15317326293
Email: sales@molnova.com
Country: China
ProdList: 4195
Advantage: 58

Ningbo Risheng Pharmaceutical Technology Co., Ltd.

Tel: 19906600019
Fax: 0574-89132888
Email: 2928184953@qq.com
Country: China
ProdList: 49
Advantage: 58

Suzhou Chenrui Biotechnology Co. LTD

Tel: 17625585511
Fax: qq：1580084073
Email: 1580084073@qq.com
Country: China
ProdList: 960
Advantage: 58

Wuhan Bo Jin Biotechnology Co.,Ltd.

Tel: 18164232327
Email: 2709603029@qq.com
Country: China
ProdList: 291
Advantage: 58

Anqing Benro pharmachem Technology Co.,Ltd.

Tel: 05565209906 15391842992
Email: 794263564@qq.com
Country: China
ProdList: 123
Advantage: 58

Less

View Lastest Price from Mobocertinib manufacturers

HangZhou RunYan Pharma Technology Co.,LTD.

Product: TAK788;Mobocertinib 1847461-43-1
Price: US $0.00-0.00/mk
Min. Order: 10mk
Purity: 99% HPLC
Supply Ability: 10000
Release date: 2024-09-19

Zibo Hangyu Biotechnology Development Co., Ltd

Product: TAK-788 1847461-43-1
Price: US $80.00-800.00/kg
Min. Order: 10kg
Purity: 0.99
Supply Ability: 20tons
Release date: 2023-10-30

1847461-43-1, MobocertinibRelated Search:

Tak 799 TAK-960 Soticlestat TAK-632 TAK875 TAK-733 Benzoic acid, 4-[[(cyclopropylmethyl)[4-(2-fluorophenoxy)benzoyl]amino]methyl]- 6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide

TAK-788

AP32788, MOBOCERTINIB

Mobocertinib

5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester

Mobocertinib (TAK788)

Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate

Mobocertinib (TAK788, AP32788)

propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate

TAK-788 (MOBOCERTINIB)

TAK788 TAK-788

ak-788 Mobotinib

propan-2-yl 2-[(4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxy-5-(prop-2-enamido)phenyl)amino]-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate

Mobutinib

1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate

Mobutinib TAK788

Mobocertinib, 10 mM in DMSO

Mobocertinib (TAK788) ，S6813

1847461-43-1

C32H39N7O4

API